SUITE 2600, CINCINNATI, OH
Chemed Corporation Annual Meeting: Directors Elected and Accountants Ratified
Reports First-Quarter 2026 Results
Announces a Five-Year $450 Million Amended and Restated Credit Agreement
Reports Fourth-Quarter 2025 Results
Reports Third-Quarter 2025 Results
Reports Second-Quarter 2025 Results and Announces Executive Management Departure
To Report Second-Quarter 2025 Earnings July 29, 2025
Shareholder votes
Q1
FY 2024
Q3
Q2
Amended Annual Report
FY 2023
Registration Statement for Securities to be Offered to Employees
Definitive Proxy Statement
Additional Proxy Soliciting Materials
Additional Proxy Materials
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Definitive Revised Proxy Statement
S-8 POS
Submission Upload
Correspondence